AI Startups

    Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

    The de-extinction startup is looking to double or triple its previous valuation, according to the report.

    TS

    TechCrunch Startups

    Source

    TechCrunch Startups
    Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
    AI Analysis

    Generated insight by OnAirToday AI

    This funding round signifies strong investor confidence in ambitious, long-term AI applications like de-extinction. Valuations this high suggest the potential for significant disruption and scientific advancement driven by AI.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at TechCrunch Startups →
    Share
    Filed under:AI Startups

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000